Pignata S, Califano D, Lorusso D, Arenare L, et al. MITO END-3: Efficacy of Avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy. Ann Oncol 2024 May 2:S0923-7534(24)00128-5. doi: 10.1016/j.annonc.2024.
PMID: 38704093